| Bioactivity | (2’,3’,5’-Tri-O-acetyl)uridine 5-carboxylic acid is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | (2’,3’,5’-Tri-O-acetyl)uridine 5-carboxylic acid |
| CAS | 174653-39-5 |
| Formula | C16H18N2O11 |
| Molar Mass | 414.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
(2’,3’,5’-Tri-O-acetyl)uridine 5-carboxylic acid
CAS: 174653-39-5 F: C16H18N2O11 W: 414.32
(2’,3’,5’-Tri-O-acetyl)uridine 5-carboxylic acid is a purine nucleoside analog. Purine nucleoside analogs have broad
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.